Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,294.50 -12.67 -0.08%
S&P 500 1,650.51 -4.84 -0.29%
Nasdaq 3,459.42 -3.88 -0.11%
Ticker Volume Price Price Delta
STOXX 50 2,776.78 -58.23 -2.05%
FTSE 100 6,696.79 -143.48 -2.10%
DAX 8,351.98 -178.91 -2.10%
Ticker Volume Price Price Delta
Nikkei 14,199.20 -284.83 -1.97%
Hang Seng 22,576.10 -93.57 -0.41%
S&P/ASX 200 4,974.70 -87.75 -1.73%
  • Exchange: NASDAQ GS
  • Sector: Consumer, Non-cyclical
  • Industry: Biotechnology
  • Sub-Industry: Medical-Biomedical/Gene

Sangamo Biosciences Inc

+ Add to Watchlist

SGMO:US

7.9300 USD 0.1200 1.54%

As of 20:10:00 ET on 05/23/2013.

Company Profile for Sangamo Biosciences Inc (SGMO)

Sangamo BioSciences, Inc. researches and develops transcription factors in the regulation of genes. These transcription factors are the proteins that turn genes on and off and regulate gene expression by recognizing specific DNA sequences.

Contact Information

Sangamo Biosciences Inc

501 Canal Boulevard
Suite A100
Richmond, CA 94804
United States
Phone: 1-510-970-6000
Fax: 1-510-236-8951

Key Executives for Sangamo Biosciences Inc (SGMO)

Edward O Lanphier IIPresident/CEO/FounderH Ward WolffExec VP/CFO
Geoffrey M Nichol "Geoff"Exec VP:Research & DevelopmentDale G AndoVP:Therapeutic Dev/Chief Medical
Philip D GregoryVP:Research/Chief Scientific Ofcr

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil